IRIS Accounts Production v24.1.4.33 05448773 Board of Directors 1.1.23 31.12.23 31.12.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh054487732022-12-31054487732023-12-31054487732023-01-012023-12-31054487732021-12-31054487732022-01-012022-12-31054487732022-12-3105448773ns15:EnglandWales2023-01-012023-12-3105448773ns14:PoundSterling2023-01-012023-12-3105448773ns10:Director12023-01-012023-12-3105448773ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3105448773ns10:SmallEntities2023-01-012023-12-3105448773ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3105448773ns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3105448773ns10:SmallCompaniesRegimeForAccounts2023-01-012023-12-3105448773ns10:FullAccounts2023-01-012023-12-3105448773ns10:Director22023-01-012023-12-3105448773ns10:Director32023-01-012023-12-3105448773ns10:RegisteredOffice2023-01-012023-12-3105448773ns5:CurrentFinancialInstruments2023-12-3105448773ns5:CurrentFinancialInstruments2022-12-3105448773ns5:ShareCapital2023-12-3105448773ns5:ShareCapital2022-12-3105448773ns5:FurtherSpecificReserve3ComponentTotalEquity2023-12-3105448773ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-3105448773ns5:RetainedEarningsAccumulatedLosses2023-12-3105448773ns5:RetainedEarningsAccumulatedLosses2022-12-3105448773ns5:LeaseholdImprovements2023-01-012023-12-3105448773ns5:FurnitureFittings2023-01-012023-12-3105448773ns5:ComputerEquipment2023-01-012023-12-3105448773ns5:LeaseholdImprovements2022-12-3105448773ns5:FurnitureFittings2022-12-3105448773ns5:ComputerEquipment2022-12-3105448773ns5:LeaseholdImprovements2023-12-3105448773ns5:FurnitureFittings2023-12-3105448773ns5:ComputerEquipment2023-12-3105448773ns5:LeaseholdImprovements2022-12-3105448773ns5:FurnitureFittings2022-12-3105448773ns5:ComputerEquipment2022-12-3105448773ns5:UnlistedNon-exchangeTradedns5:CostValuation2022-12-3105448773ns5:UnlistedNon-exchangeTradedns5:RevaluationsIncreaseDecreaseInInvestments2023-12-3105448773ns5:UnlistedNon-exchangeTradedns5:TransfersBetweenInvestmentClassesIncreaseDecreaseInInvestments2023-12-3105448773ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-12-3105448773ns5:UnlistedNon-exchangeTraded2023-12-3105448773ns5:UnlistedNon-exchangeTraded2022-12-3105448773ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3105448773ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-12-3105448773ns5:FurtherSpecificReserve3ComponentTotalEquity2022-12-31
REGISTERED NUMBER: 05448773 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

CAVENDISH MEDICAL LIMITED

CAVENDISH MEDICAL LIMITED (REGISTERED NUMBER: 05448773)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


CAVENDISH MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTORS: Mr S A Bruce
Mr P Convey
Dr B E Holdsworth





REGISTERED OFFICE: Devon House
171-177 Gt Portland Street
London
W1W 5PQ





REGISTERED NUMBER: 05448773 (England and Wales)





ACCOUNTANTS: Cube Partners Limited
Chartered Accountants
5 Giffard Court
Millbrook Close
Northampton
Northamptonshire
NN5 5JF

CAVENDISH MEDICAL LIMITED (REGISTERED NUMBER: 05448773)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 294,814 94,938
Investments 5 - 110,317
294,814 205,255

CURRENT ASSETS
Debtors 6 149,914 422,481
Investments 7 116,248 -
Cash at bank 993,836 1,440,653
1,259,998 1,863,134
CREDITORS
Amounts falling due within one year 8 654,314 970,717
NET CURRENT ASSETS 605,684 892,417
TOTAL ASSETS LESS CURRENT
LIABILITIES

900,498

1,097,672

PROVISIONS FOR LIABILITIES 61,686 20,782
NET ASSETS 838,812 1,076,890

CAPITAL AND RESERVES
Called up, fully paid share capital 100,000 100,000
Fair value reserve 10 21,917 15,987
Retained earnings 716,895 960,903
838,812 1,076,890

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 July 2024 and were signed on its behalf by:





Mr S A Bruce - Director


CAVENDISH MEDICAL LIMITED (REGISTERED NUMBER: 05448773)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023

1. STATUTORY INFORMATION

Cavendish Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 15% on cost
Fixtures and fittings - 15% on reducing balance
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Fixed asset investments
Investments in shares are included at fair value.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 37 (2022 - 33 ) .

CAVENDISH MEDICAL LIMITED (REGISTERED NUMBER: 05448773)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 January 2023 36,112 170,342 130,708 337,162
Additions 183,906 43,574 54,039 281,519
Disposals (36,112 ) - (87,322 ) (123,434 )
At 31 December 2023 183,906 213,916 97,425 495,247
DEPRECIATION
At 1 January 2023 24,303 118,499 99,422 242,224
Charge for year 34,983 12,134 23,281 70,398
Eliminated on disposal (24,867 ) - (87,322 ) (112,189 )
At 31 December 2023 34,419 130,633 35,381 200,433
NET BOOK VALUE
At 31 December 2023 149,487 83,283 62,044 294,814
At 31 December 2022 11,809 51,843 31,286 94,938

5. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST OR VALUATION
At 1 January 2023 110,317
Revaluations 5,931
Reclassification/transfer (116,248 )
At 31 December 2023 -
NET BOOK VALUE
At 31 December 2023 -
At 31 December 2022 110,317

Investments in shares are included at fair value.

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 18,360 11,583
Amounts owed by group undertakings - 322,039
Other debtors 131,554 88,859
149,914 422,481

7. CURRENT ASSET INVESTMENTS
2023 2022
£    £   
Unlisted investments 116,248 -

CAVENDISH MEDICAL LIMITED (REGISTERED NUMBER: 05448773)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2023

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 61,443 52,535
Taxation and social security 378,735 524,919
Other creditors 214,136 393,263
654,314 970,717

9. LEASING AGREEMENTS

At 31 December 2023 the company was committed to making payments of £111,392 ( 2022 £20,235) under non-cancellable operating leases.

10. RESERVES
Fair
value
reserve
£   
At 1 January 2023 15,987
Revaluation of investments 5,930

At 31 December 2023 21,917